Download the whitepaper

The Direct-to-Patient Paradigm Shift

Direct-to-Patient (DTP) models, pioneered by platforms like LillyDirect, NovoCare, and PfizerForAll, are redefining how healthcare is delivered, commercialized, and experienced. But as pharma brands invest millions into building direct digital corridors, how are patients and healthcare providers (HCPs) actually responding?  

Download the whitepaper to understand perceptions and usage of DTP platforms from a comprehensive survey of over 1,398 patients and 64 HCPs.